1800-272-662
Shopping Cart 0
countryflagAU
Login

Epsilon Healthcare Ltd

Healthcare AU EPN

0.025AUD
-(-%)

Last update at 2026-03-13T00:34:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.020.04
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap9.73M
  • Volume3280
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.66724M
  • Revenue TTM9.39M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 5.65M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.01746M -5.57349M -3.30666M -12.67747M -10.36582M
Minority interest - - - - -
Net income -2.05066M -3.24633M -1.09099M -12.67747M -8.90840M
Selling general administrative - 1.70M 2.87M 3.91M 6.85M
Selling and marketing expenses - 0.20M 0.21M 0.34M 0.42M
Gross profit 2.25M 4.17M 4.81M 1.34M 2.06M
Reconciled depreciation - 1.41M 1.48M 1.86M 1.56M
Ebit -2.21739M -4.88316M -2.79145M -9.54580M -7.05131M
Ebitda -1.85880M -2.13288M -1.31263M -7.69029M -5.49339M
Depreciation and amortization 0.36M 2.75M 1.48M 1.86M 1.56M
Non operating income net other - - - - -
Operating income -2.21739M -4.18701M -2.41589M -9.54580M -7.05131M
Other operating expenses 11.61M 7.73M 7.59M 16.80M 15.00M
Interest expense 1.26M 1.15M 0.52M 0.58M 0.80M
Tax provision - -0.13339M -2.21567M 0.00000M -1.45742M
Interest income - 1.14M 0.49M 0.60M 0.83M
Net interest income - -1.15102M -0.51521M -0.67763M -0.79939M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.96680M 2.33M -2.21567M 0.82M -1.45742M
Total revenue 9.39M 5.60M 6.65M 7.11M 5.50M
Total operating expenses 4.47M 6.31M 5.75M 11.03M 11.56M
Cost of revenue 7.14M 1.43M 1.84M 5.78M 3.44M
Total other income expense net -0.80007M -1.38648M -0.89078M -2.30999M -0.06704M
Discontinued operations - - - - -
Net income from continuing ops - -5.49374M -1.09099M -12.67747M -8.90840M
Net income applicable to common shares - -5.49374M -1.09099M -13.28856M -9.24318M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 17.87M 10.46M 14.41M 20.50M 30.55M
Intangible assets - - - 0.00000M 0.50M
Earning assets - - - - -
Other current assets 0.30M 0.19M 0.03M 0.76M 0.71M
Total liab 14.88M 12.53M 6.87M 11.23M 10.98M
Total stockholder equity 2.99M -2.07721M 7.54M 9.27M 19.57M
Deferred long term liab - - - - -
Other current liab 0.34M 0.23M 0.54M 0.74M 1.09M
Common stock 48.27M - - 46.88M 44.82M
Capital stock - 47.53M 46.81M 46.88M 44.82M
Retained earnings -51.66136M -53.59090M -48.09716M -48.97157M -35.96932M
Other liab - - - 2.65M 3.19M
Good will - - - 0.00000M 4.47M
Other assets - - - 0.12M 0.13M
Cash 0.24M 1.57M 0.34M 0.86M 2.34M
Cash and equivalents - - - - -
Total current liabilities 4.61M 11.50M 6.37M 7.93M 7.14M
Current deferred revenue 0.44M - - 0.64M 0.93M
Net debt 13.92M 6.29M 2.95M 2.34M 1.99M
Short term debt 0.58M - - 2.54M 3.67M
Short long term debt - 7.85M 3.29M 2.55M 3.55M
Short long term debt total 14.16M - - 3.20M 4.33M
Other stockholder equity - - - -0.61109M -0.74895M
Property plant equipment - - - 15.62M 17.48M
Total current assets 5.27M 3.69M 2.09M 4.76M 7.81M
Long term investments - - - - 0.13M
Net tangible assets - - - 9.88M 14.44M
Short term investments - - - - -
Net receivables 3.52M 0.90M 1.13M 3.15M 2.16M
Long term debt - - - - -
Inventory 1.20M 0.53M - 0.61M 2.42M
Accounts payable 3.26M 2.59M 1.20M 4.65M 2.38M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 6.38M - - 11.98M 11.47M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.44M 0.07M 0.07M 0.12M 0.13M
Deferred long term asset charges - - - - -
Non current assets total 12.60M 6.77M 12.32M 15.74M 22.74M
Capital lease obligations - 0.03M 0.16M 0.65M 0.78M
Long term debt total - - - 0.65M 0.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.09773M -0.09912M -0.52940M -0.73759M
Change to liabilities - - - 0.00000M 0.31M
Total cashflows from investing activities 6.29M -0.09773M -0.09912M -0.52940M -0.73759M
Net borrowings - 4.13M 0.49M -1.28191M -0.92974M
Total cash from financing activities -4.48238M 4.73M 0.34M 1.61M 1.47M
Change to operating activities - - - - -
Net income -2.05066M -3.24633M -1.09099M -12.67747M -9.24318M
Change in cash -1.32279M 1.22M -0.46658M -1.47358M -4.63237M
Begin period cash flow 1.57M 0.34M 0.81M 2.34M 6.97M
End period cash flow 0.24M 1.57M 0.34M 0.86M 2.34M
Total cash from operating activities -3.12666M -3.40560M -0.70337M -2.57065M -5.42942M
Issuance of capital stock - 0.72M - - 2.45M
Depreciation 0.36M 2.75M 0.00148M 1.86M 1.09M
Other cashflows from investing activities -0.24400M 0.00000M 0.00097M 0.00000M 0.01M
Dividends paid - - - - -
Change to inventory - - - - -0.45661M
Change to account receivables - - 1.71M - -0.84375M
Sale purchase of stock - 0.72M 0.00000M 2.89M 2.51M
Other cashflows from financing activities -0.24488M 4.13M -0.15629M -0.52940M -0.56470M
Change to netincome - - - 8.24M 3.66M
Capital expenditures 0.17M 0.10M 0.10M 0.53M 0.75M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 0.30M 0.00189M 1.11M 1.04M
Stock based compensation - - 0.00005M - -
Other non cash items -1.43460M -2.90956M 0.38M - -
Free cash flow -3.29640M -3.50333M -0.80346M -0.52940M -0.74771M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EPN
Epsilon Healthcare Ltd		 - -% 0.03 - - 1.04 3.12 1.93 -0.8145
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.08 19.88 1.35 3.81 1.72 13.67
VLS
Vita Life Sciences Ltd		 -0.02 0.80% 2.48 13.89 42.73 1.46 2.42 1.24 6.53
SNT
Syntara Ltd		 -0.001 3.33% 0.03 - 20.45 6.32 4.62 6.32 -2.1607
MVP
Medical Developments International Ltd		 0.005 1.23% 0.41 - 166.67 1.14 0.83 0.75 11.48

Reports Covered

Stock Research & News

View All

Profile

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulations; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.

Epsilon Healthcare Ltd

5 Goodyear Street, Southport, QLD, Australia, 4215

Key Executives

Name Title Year Born
Mr. Sonny Didugu Group COO & Joint Company Sec. NA
Ms. Laura Harvey Chief Operations Officer - Canada NA
Ms. Diandra Phipps Chief Operating Officer of Tetra Health NA
Mr. Mark Audet CFO & Joint Company Sec. NA
Mr. Jim Barlow Chief Agronomist and Regional Mang. of the Americas NA
Mr. Xiao Cui Executive Chairman NA
Mr. Daniel Sanghera Interim Chief Executive Officer NA
Ms. Li Lin Group Financial Controller NA
Mr. Marcelo Mora Company Secretary NA
Mr. Xiao Cui Executive Chairman NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.